Shares of Blue Jet Healthcare Ltd. jumped over 6% to ₹816.85 in early trade on May 15 after the company reported a robust set of Q4 FY25 results. The pharma firm posted a 177% year-on-year surge in net profit to ₹110 crore, compared to ₹39.65 crore in the corresponding quarter of the previous year. The sharp rise in profitability was supported by strong operational growth and improved margins.
Total income for Q4 FY25 stood at ₹352.67 crore, up significantly from ₹192.78 crore in Q4 FY24. Revenue from operations increased to ₹340.45 crore, marking a 85% rise from ₹183.95 crore a year ago. Even as expenses rose to ₹205.46 crore from ₹138.62 crore, the company’s operating efficiency enabled a strong jump in profit before tax to ₹147.21 crore versus ₹54.15 crore in Q4 FY24.
For the full year FY25, Blue Jet Healthcare’s net profit grew by 87% to ₹305.20 crore, compared to ₹163.76 crore in FY24. Annual revenue from operations climbed to ₹1,029.98 crore, up from ₹711.60 crore in the previous year. Total income for FY25 reached ₹1,076.24 crore, reflecting a year-on-year growth of over 45%.
The company’s strong performance was driven by higher operational leverage, improved inventory management, and steady employee expenses. The upbeat results fueled bullish sentiment in the market, pushing the stock higher during Thursday’s session.
